Navigation Links
Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
Date:9/23/2011

ce. July 2011, Washington, D.C.
  • Harabayashi, et al. Management of renal angiomyolipomas associated with Tuberous Sclerosis Complex. J Urol 2004;171(1):102-105.
  • Singer. Angiomyolipoma. Available at http://www.medscape.com/viewarticle/415099.  Accessed September 2011.
  • Motzer, et al. Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma. Cancer 2010 Sep;116(18):4256-4265.
  • Krueger, et al. Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis. New Eng J Med 2010;363:1801-11.
  • US National Institutes of Health. Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2). Available at: http://clinicaltrials.gov/ct2/show/NCT00790400?term=exist-2&rank=1.  Accessed September 2011.

  • Novartis Media RelationsMedia only:Investors only:Nicole Riley

    Richard JarvisNovartis Oncology

    Novartis CorporationP: +1 862 778 3110

    P: +1 212 830 2433Dana Kahn Cooper

    investor.relations@novartis.comP: +1 732 817 1800F: +1 732 817 1834For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis

    For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.


    '/>"/>

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
    2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
    3. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
    4. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
    5. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
    6. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
    7. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
    8. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
    9. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
    10. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
    11. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
    (Date:12/24/2014)... and LONDON , December 24, 2014 ... are expected to grow at an average rate of ... value and volume. Hip, knee and spine surgeries are ... in emerging economies they have a lower penetration. Increased ... the use of composites. Non-metallic orthopedic devices have gained ...
    (Date:12/24/2014)... 2014 LifeScienceIndustryResearch.com adds ... Syringe Industry of 178 pages providing 10 ... library. The 2014 Market Research ... a professional and deep research report on ... the report introduces Disposable Syringe basic information ...
    Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
    ... , May 8 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger of ... the Bank of America Merrill Lynch Health Care Conference being held ... in New York, New York .  Jon Russell, Vice President, ...
    ... SWANTON, Vt ., May 7 This May, ... in their effort to spread Multiple Chemical Sensitivity Syndrome awareness.   , ... AllerAir will make chemical awareness ... at www.allerair.com .  Additionally, their blogs and articles ...
    Cached Medicine Technology:Multiple Chemical Sensitivities Are Real 2Multiple Chemical Sensitivities Are Real 3
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... on a "fountain of youth" drug that can delay the ... a new study suggests. Seniors received a significant boost ... a genetic signaling pathway linked to aging and immune function, ... The experimental medication, a version of the drug rapamycin, improved ...
    (Date:12/25/2014)... December 25, 2014 Thousands of transvaginal ... forward in a number of multidistrict litigations currently underway ... Bernstein Liebhard LLP reports. According to an Order issued ... convene a Joint Status Conference in all of the ... have been directed to submit a proposed agenda to ...
    (Date:12/25/2014)... 25, 2014 Plugin creators from Pixel ... A fully customizable business presentation tool made specifically for ... ProFire 5k business tool, users can now display their ... of Pixel Film Studios. “ProFire 5k gives users a ... add professionalism to a presentation” , Pixel Film Studios ...
    (Date:12/25/2014)... CA (PRWEB) December 25, 2014 Each ... visits and 2 million hospital admissions across the nation ... Prevention ). The CDC’s National Hospital Ambulatory Medical ... through a survey conducted in 2010. They estimated that ... visits that resulted in a primary diagnosis of broken ...
    (Date:12/24/2014)... Wi (PRWEB) December 25, 2014 AlignLife ... are unable to afford certain items. During the holiday season, ... "We collected over 70 toys," says Dr. Sara Mahalko-Leonhardt, owner ... and staff such joy, knowing that we are able to ... present had it not been for the generosity of our ...
    Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2
    ... prescription drugs , THURSDAY, April 8 (HealthDay News) -- Medical ... included -- are poorly informed about herbal medicines and that ... misplaced, according to a new survey. , The survey was ... and Therapeutics Bulletin , which published the results online April ...
    ... ... Research Behind Their Products , ... Provo, UT (Vocus) April 8, 2010 -- Tahitian Noni International (TNI) now has ... are on the way. TNI has more human clinical studies than any network marketing superfruit ...
    ... Thomas Mower Sr., Chairman of ... in the growth and success of Sportsmen for Fish and Wildlife (SFW), according to Founder Don ... Salt Lake City (PRWEB) April ... of the Utah Jazz, have been key players in the growth and success of Sportsmen for ...
    ... ... Medical Design Excellence Awards competition, one of the most prestigious awards in the medical ... ... recognized in the 2010 Medical Design Excellence Awards competition, one of the most prestigious ...
    ... ... week to discuss how to start your own porn site. , ... (PRWEB) April 8, 2010 -- The Phoenix Forum is Thursday, April 8th ... of Teleteria would love to go over ways to improve your traffic and revenue stream in ...
    ... ... and positioning of healthcare technology solutions. , ... (PRWEB) April 8, 2010 -- CapSite™ Consulting, ... comparisons of contracts and proposals for Healthcare IT, Imaging Equipment and Medical Device ...
    Cached Medicine News:Health News:Insight on Herbals Eludes Doctors, Patients Alike 2Health News:14 Human Clinical Studies Prove the Efficacy of Tahitian Noni Bioactive Beverages 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 3Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 4Health News:ROBRADY Design's Work with Xhale Innovations Inc. Wins 2010 Medical Design Excellence Awards 2Health News:ROBRADY Design's Work with Xhale Innovations Inc. Wins 2010 Medical Design Excellence Awards 3Health News:Jay Servidio President Teleteria Appearances To Discuss The Porn Business This Week 2Health News:CapSite™ Provides Detailed Transparency on Healthcare Technology Purchases 2
    Family Practice: Letter Acuity, Astigmatic,Clock, Tumbling E, and Allen Tests....
    Acuity Astigmatism: Letter Acuity, Astigmatic Clock, Number Acuity, and Tumbling E Tests....
    ... called the Prostate Specific Antigen (total PSA) test, ... to manage patients with prostate cancer. Of the ... test, was the first approved for the detection ... digital rectal examination (DRE) in men aged 50 ...
    ... Smile Tests at 480 and 120 ... for children of 6,months to 5 years ... ,Stereo Smile Tests screen for:, Amblyopia, Strabismus, ... Test Includes:, 1 demonstration card, 1 pair ...
    Medicine Products: